Home -> Law Blog Directory -> Legal News Blogs -> Fastcase Legal News
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Legal News
: Fastcase Legal NewsWhy Aren't NFL Instant Replays Reviewed De Novo?
ADVERTISEMENTS
Duke Law professor Joseph Blocher asks a great question: Why Aren't Instant Replays Reviewed De Novo?He argues that unlike trial courts, umpires and referees operating in real time are not in the best place to make the correct call. After all, in sports, the reviewing decision-maker is viewing the play multiple times, from many angles, and in slow motion.
Cited in the blog post is a forthcoming Indiana Law Review article by Chad M. Oldfather and Matthew M Fernholz of Marquette University Law School: Comparative Procedure on a Sunday Afternoon: Instant Replay in the NFL as a Process of Appellate Review.
Check out the comments to Blocher's post for extra entertainment. Pretty good.
Source: PrawfsBlawg
Full post as published by Fastcase Legal News on December 10, 2009 (boomark / email).
Lawsuits and Settlements
Mr. Brown Instant Coffee
Possible Melamine Contamination Prompts Canadian Agency to Issue Warning
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

Football and the Law: Why Are Instant Replays Reviewed De Novo
Why Aren't Instant Replays Reviewed De Novo
Instant Replay: Let's See That One More Time
Why Aren't NFL Instant Replays Reviewed De Novo
Why Instant Replay Should be Like de novo Appellate Review
Novo Nordisk Fails to Show Reasonable Likelihood of Success Over Sanofi







